Cleveland Clinic/Kaiser Permanente Residency Program
M.chelonae abscessus Lower Extremity
Infection in the DoubleTransplan...
Objectives
✤ Mycobacterium chelonae abscessus is a rare cause of human infection
✤ Present an atypical manifestation in an...
Case Study
History of Present Illness
✤ December 2010, a 56yo male presents with pain to the right 4th MTPJ
✤ 2 months prior
✤ Clippi...
History of Present Illness
✤ 2 weeks after I&D
✤ Noticed increased pain and erythema at anesthetic injection site
of the r...
History of Present Illness
✤ The patient describes the pain thusly:
✤ It begins at night, worsens until the morning, and r...
Past Medical History
✤ DM Type I x 35 years
✤ Status-post cadaveric pancreas transplant 10 years prior
✤ Status-post livin...
✤ Past Surgical History
✤ Cadaveric pancreas transplant
✤ Living-donor kidney transplant
✤ Multiple eye surgeries
✤ Right ...
Medications
✤ Prednisone
✤ Tacrolimus anhydrous (Prograf)
✤ Mycophenolate mofetil
(Cellcept)
✤ Bupropion
✤ Zetia
✤ Prilose...
✤ Social History
✤ Lives by Lake Michigan
✤ Often spends his summers on the beaches
✤ Illicit drug use: denies
Physical Exam: Right Foot
✤
Vascular: DP/PT pulses palpable. No edema. No dependent rubor
✤
Neurological: Light touch inta...
Ancillary
Studies
✤ MRI without contrast
✤ Nonspecific soft tissue edema
✤ No focal soft tissue abnormality
✤ ABI/PVR
✤ Rig...
Plan
✤ ADMISSION
✤ Course of IV antibiotics
✤ IV Zosyn and Vancomycin
✤ During admission
✤ Patient remained afebrile
✤ Min...
✤ Six-week course of IV antibiotics
✤ Despite the six-week course of IV antibiotics...
✤ The erythema failed to improve
✤ ...
SixWeeks After Discharge
✤ Evaluated by Podiatry and Infectious Disease
✤ Plan
✤ Admission
✤ Underlying ischemia?
✤ Multid...
During
Admission
✤ Vitals: afebrile
✤ Physical exam remained unchanged
✤ Labs
✤ No leukocytosis
✤ ESR: 1
✤ CRP: 0.1
✤ Proc...
✤ After a multidisciplinary discussion, it was determined to halt the
current administration of antibiotics
✤ Evaluate the...
Two Months from Initial
Presentation
✤ Increased pain to the right 4th
MTPJ
✤ New complaint of a “lump” to
the area
✤ Deni...
PLAN
Plan
✤ Aspiration
✤ Anaerobe/aerobe
✤ AFB stain and culture
✤ Fungal culture and smear
✤ Nocardia
✤ Mycoplasma
✤ Admission
During Admission
✤ Patient remained afebrile
✤ Labs
✤ No leukocytosis
✤ ESR and CRP remained unchanged
✤ Microbiology
✤ Ra...
At Discharge
✤ Final cultures demonstrated
✤ Mycobacterium chelonae abscessus
✤ S: clarithromycin/azithromycin, linezolid,...
At Six Months
Discussion
Mycobacterium chelonae abscessus
✤ Multi-drug resistant, rapid-growing acid fast bacilli
✤ Chopra et al. J Antimicrob Chem...
Mycobacterium chelonae abscessus
✤ Cause of nosocomial, post-surgical wound, and post-injection abscesses
✤ Clustered case...
Mycobacterium chelonae abscessus
✤
Several reported cases among solid organ transplant patients
✤
Cooper et al. Am J Med, ...
Mycobacterium chelonae abscessus
✤ Diagnosis and treatment are complex
✤ Lesion biopsy and wound culture with susceptibili...
Conclusion
✤ Multi-drug resistant acid-fast bacilli with proclivity for the
immunocompromised
✤ Treatment of these infecti...
References
✤ Morales P, Gil A, Santos M. Mycobacterium abscessus infection in transplant recipients. Transplantation Proce...
ThankYou
Upcoming SlideShare
Loading in …5
×

Mycobacterium Chelonae Abscessus Lower Extremity Infection in the Double Transplant Patient

688 views

Published on

Published in: Education, Health & Medicine
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
688
On SlideShare
0
From Embeds
0
Number of Embeds
6
Actions
Shares
0
Downloads
4
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Mycobacterium Chelonae Abscessus Lower Extremity Infection in the Double Transplant Patient

  1. 1. Cleveland Clinic/Kaiser Permanente Residency Program M.chelonae abscessus Lower Extremity Infection in the DoubleTransplant Patient Jennifer Gerres DPM, PGY-2
  2. 2. Objectives ✤ Mycobacterium chelonae abscessus is a rare cause of human infection ✤ Present an atypical manifestation in an immunosuppressed patient ✤ Review of the literature ✤ Proclivity for the renal transplant patient
  3. 3. Case Study
  4. 4. History of Present Illness ✤ December 2010, a 56yo male presents with pain to the right 4th MTPJ ✤ 2 months prior ✤ Clipping toenails and accidentally clipped right 4th toe ✤ Developed pain and edema ✤ Saw his local podiatrist in Michigan ✤ I&D performed, and per patient, purulent material was expressed, but no culture taken
  5. 5. History of Present Illness ✤ 2 weeks after I&D ✤ Noticed increased pain and erythema at anesthetic injection site of the right 4th toe ✤ Returned to podiatrist, who prescribed empiric Augmentin x 10 days without improvement ✤ Epsom salt soaks twice daily ✤ Radiograph of right foot: calcified vessels ✤ ABI/PVR: small vessel disease
  6. 6. History of Present Illness ✤ The patient describes the pain thusly: ✤ It begins at night, worsens until the morning, and resolves by midmorning ✤ Sharp, “tight-feeling” at the base of the right 4th toe ✤ Review of Systems ✤ Denies n/v/f/c/night sweats/weight change/loss of appetite ✤ Previous right foot surgery ✤ Distal chevron bunionectomy ✤ “It took 6 months for the incision to heal”
  7. 7. Past Medical History ✤ DM Type I x 35 years ✤ Status-post cadaveric pancreas transplant 10 years prior ✤ Status-post living-donor kidney transplant 10 years prior ✤ Aortic Stenosis ✤ Glaucoma (legally blind) ✤ Hypothyroidism ✤ Irritable bowel syndrome
  8. 8. ✤ Past Surgical History ✤ Cadaveric pancreas transplant ✤ Living-donor kidney transplant ✤ Multiple eye surgeries ✤ Right HAV surgery 3 years prior ✤ Allergies ✤ No known drug allergies
  9. 9. Medications ✤ Prednisone ✤ Tacrolimus anhydrous (Prograf) ✤ Mycophenolate mofetil (Cellcept) ✤ Bupropion ✤ Zetia ✤ Prilosec ✤ Synthroid ✤ Betimol 0.5% eye drops ✤ Lotemax 0.5% eye drops ✤ Aspirin 81mg ✤ Calcium carbonate/VitD3
  10. 10. ✤ Social History ✤ Lives by Lake Michigan ✤ Often spends his summers on the beaches ✤ Illicit drug use: denies
  11. 11. Physical Exam: Right Foot ✤ Vascular: DP/PT pulses palpable. No edema. No dependent rubor ✤ Neurological: Light touch intact. SWMF 5.07 intact to all sites ✤ Musculoskeletal: Pain with ROM of the 4th MTPJ ✤ Pain on palpation at the 4th MTPJ and the 3rd interspace ✤ Negative Mulder’s click ✤ No pain to palpation of the 4th toe ✤ Dermatological: telangiectasias to dorsal forefoot ✤ No palpable mass ✤ Erythema to the distal pulp of the 4th toe as well as to the dorsal 4th MTPJ ✤ The erythema is blanchable
  12. 12. Ancillary Studies ✤ MRI without contrast ✤ Nonspecific soft tissue edema ✤ No focal soft tissue abnormality ✤ ABI/PVR ✤ Right: 1.16 TBI: 0.42 small vessel disease ✤ Left: 1.1 TBI: 0.63
  13. 13. Plan ✤ ADMISSION ✤ Course of IV antibiotics ✤ IV Zosyn and Vancomycin ✤ During admission ✤ Patient remained afebrile ✤ Minimal resolution of erythema to the 4th MTPJ, but no resolution of pain ✤ Labs ✤ No leukocytosis ✤ ESR: 2 ✤ CRP: 0.1 ✤ Uric acid: wnl
  14. 14. ✤ Six-week course of IV antibiotics ✤ Despite the six-week course of IV antibiotics... ✤ The erythema failed to improve ✤ Patient continued to have pain at the right 4th MTPJ After Discharge
  15. 15. SixWeeks After Discharge ✤ Evaluated by Podiatry and Infectious Disease ✤ Plan ✤ Admission ✤ Underlying ischemia? ✤ Multidisciplinary approach
  16. 16. During Admission ✤ Vitals: afebrile ✤ Physical exam remained unchanged ✤ Labs ✤ No leukocytosis ✤ ESR: 1 ✤ CRP: 0.1 ✤ Procalcitonin: <0.05 ✤ MRI with contrast ✤ Mild, nonspecific subcutaneous and muscular edema
  17. 17. ✤ After a multidisciplinary discussion, it was determined to halt the current administration of antibiotics ✤ Evaluate the patient in the outpatient setting ✤ Weekly photographs and phone calls ✤ The patient provided weekly updates until February 2011
  18. 18. Two Months from Initial Presentation ✤ Increased pain to the right 4th MTPJ ✤ New complaint of a “lump” to the area ✤ Denied n/v/f/c/night sweats
  19. 19. PLAN
  20. 20. Plan ✤ Aspiration ✤ Anaerobe/aerobe ✤ AFB stain and culture ✤ Fungal culture and smear ✤ Nocardia ✤ Mycoplasma ✤ Admission
  21. 21. During Admission ✤ Patient remained afebrile ✤ Labs ✤ No leukocytosis ✤ ESR and CRP remained unchanged ✤ Microbiology ✤ Rapid-growing, acid fast bacilli
  22. 22. At Discharge ✤ Final cultures demonstrated ✤ Mycobacterium chelonae abscessus ✤ S: clarithromycin/azithromycin, linezolid, tigecycline ✤ Antibiotic regimen ✤ Tigecycline 50mg IV q12h ✤ Azithromycin 500mg PO ✤ Linezolid 600mg PO q12h ✤ Local wound care for ulceration
  23. 23. At Six Months
  24. 24. Discussion
  25. 25. Mycobacterium chelonae abscessus ✤ Multi-drug resistant, rapid-growing acid fast bacilli ✤ Chopra et al. J Antimicrob Chemother, 2011: ✤ Systematic review, screening 1040 approved drugs, antimicrobial and non-antimicrobial ✤ Discovered 32 compounds with significant antimicrobial activity ✤ Illustrated the resilience of this group ✤ Biofilm ✤ Ubiquitous and fastidious ✤ Found: water
  26. 26. Mycobacterium chelonae abscessus ✤ Cause of nosocomial, post-surgical wound, and post-injection abscesses ✤ Clustered cases of infection ✤ Foot baths, contaminated water supply or injected material ✤ Infrequently, a cause of infection ✤ Immunocompromised ✤ Solid organ transplants ✤ Cutaneous lesions of the extremities ✤ Arthritis and tenosynovitis; meningitis; and disseminated infection
  27. 27. Mycobacterium chelonae abscessus ✤ Several reported cases among solid organ transplant patients ✤ Cooper et al. Am J Med, 1989: ✤ Identified 7 renal transplant patients ✤ Distinct pattern emerged: ✤ Indolent, tender nodules isolated to the lower extremities ✤ Absence of systemic symptoms and no leukocytosis ✤ Garrison et al. Transpl Infect Dis, 2009: ✤ Found 25 cases involving solid organ transplant recipients ✤ 4 received renal transplants
  28. 28. Mycobacterium chelonae abscessus ✤ Diagnosis and treatment are complex ✤ Lesion biopsy and wound culture with susceptibility ✤ Resistance patterns unpredictable ✤ Naturally resistant to conventional anti-TB drugs ✤ No guidelines as to duration of therapy ✤ IDSA ✤ 4 months for skin and soft tissue infections ✤ 6 months for bone infections ✤ Chernenko et al. J Hear Lung Transplant, 2006: ✤ 12 to 18 months of combination therapy in the immunocompromised ✤ Surgical intervention
  29. 29. Conclusion ✤ Multi-drug resistant acid-fast bacilli with proclivity for the immunocompromised ✤ Treatment of these infections are complex ✤ Culture and sensitivity are imperative ✤ Aspiration and/or debridement necessary to improve outcome
  30. 30. References ✤ Morales P, Gil A, Santos M. Mycobacterium abscessus infection in transplant recipients. Transplantation Proceedings. 2010;42:3058-306 ✤ Morris-Jones R, Fletcher C, Morris-Jones S, et al. Mycobacterium abscessus : a cutaneous infection in a patient on renal replacement therapy. Clin Exp Dermatol. 2001;26:415-418 ✤ Garrison, AP, Morris MI, Lewis SD, et al. Mycobacterium abscessus infection in solid organ trasnplant recipients : report of three cases and review of the literature. Transpl Infect Dis. 2009;11:541-548 ✤ Moore M, Frerichs JB. An unusual acid-fast infection of the knee with subcutaneous, abscess-like lésions of the gluteal région ; report of a case with a study of the organism, Mycobacterium abscessus, n. sp. J Invest Dermatol. 1953 ;20 :133-169 ✤ Chopra S, Matsuyama K, Hutson C, Madrid P. Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae. J Antimicrob Chemother. 2011;66:1533-1436 ✤ Kwon YH, Lee GY, Kim WS, Kim JK. A case of skin and soft tissue infection caused by mycobacterium abscessus. Ann Dermatol (Seoul). 2009;21(1) :84-87 ✤ Doucette K, Fishman JA. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis. 2004;38(10):1428-1439 ✤ Galil K, Miller LA, Yakrus MA, et al. Abscesses due to Mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis. 1999;5:681-687 ✤ Cooper JF, Lichtenstein MJ, Graham BS, Schaffner W. Mycobacterium chelonae: A cause of nodular skin lesions with a proclivity for renal transplant recipients. Am J Med. 1989;86(2):173-177 ✤ Prinz BM, Michaelis S, Kettelhack N, et al. Subcutaneous infection with Mycobacterium abscessus in a rental transplant recipient. Dermatology. 2004;208(3)259-261 ✤ Scholze A, Loddenkemper C, Grumbaum M, et al. Cutaneous Mycobacterium abscessus infection after kidney transplantation. Nephrol Dial Transplant. 2005;20(8): 1764-1765 ✤ Chernenko SM, Humar A, Hutcheon M, et al. Mycobacterium abscessus infections in lung transplant recipients : the international experience. J Hear Lung Transplant. 2006;25(12):1447-1455
  31. 31. ThankYou

×